Tag: vascular stent market insights

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Vascular Stent Market Size Changed, over the years?

The dimension of the vascular stent market has seen robust growth over the recent years. It is expected to rise from a $15.85 billion valuation in 2024 to $17.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.5%. This substantial growth during the historic period is driven by clinical studies and advancements, developments in drug-eluting stents (des), the emergence of balloon angioplasty, initial stent inventions, and improvements in physician training and skills.

How Much Will the Vascular Stent Market Be Worth in 2029?

The market size of vascular stents is anticipated to experience a swift expansion in the upcoming years, escalating to $25.76 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period can be linked to the emphasis on preventative care in cardiovascular health, the shift to outpatient procedures, price efficiency and value-driven healthcare, the emergence of bioabsorbable stents and next-gen materials, and the broadening scope of endovascular interventions. Key trends during this forecast period include improvements in the coatings and materials used for stents, increased patient knowledge and awareness, the movement towards outpatient settings, and an emphasis on cost-effectiveness.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Which is the Largest Company in the Vascular Stent Market?

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

What Are the Main Market Drivers in the Vascular Stent Industry?

The escalating occurrence of vascular disorders is expected to boost the vascular stent market’s progress. Vascular disease, a subset of cardiovascular diseases (CVD), is an abnormality affecting the blood vessels including arteries and veins. Vascular stents play a vital role in managing a variety of vascular diseases by facilitating the flow of oxygen-laden blood to the heart. For example, the Center for Disease Control and Prevention, an American public health federal agency, reported in May 2023 that in 2022, about 702,880 individuals in the United States succumbed to heart disease, equating to one in every five deaths. Consequently, rising instances of cardiovascular diseases (CVDs) will stimulate growth in the vascular stent market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8363&type=smp

How Is the Vascular Stent Market Segments Structured?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

What Strategic Trends Are Transforming the Vascular Stent Market?

The vascular stent market is increasingly influenced by the trend of technological advancements. Numerous firms are leveraging bio-sensing devices, top-notch integrated stents, and drug-deluting coronary stent systems for gaining a competitive advantage. For example, in 2022, India’s medical equipment manufacturing company, Translumina, introduced VIVO ISAR, an advanced generation polymer-free coated dual drug stent (DDCS) that pairs a stent with an enhanced safety profile without affecting the drug release kinetics. The stent uses Probucol, a lipid-lowering and antioxidant medication, to deliver Sirolimus, a drug combating restenosis, offering a polymer-free DES platform prioritizing safety and efficacy without any compromises.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Which Global Regions Offer the Highest Growth in the Vascular Stent Market?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

This Report Delivers Insight On:

1. How big is the vascular stent market, and how is it changing globally?

2. Who are the major companies in the vascular stent market, and how are they performing?

3. What are the key opportunities and risks in the vascular stent market right now?

4. Which products or customer segments are growing the most in the vascular stent market?

5. What factors are helping or slowing down the growth of the vascular stent market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Vascular Stent Market Size Changed, over the years?

The dimension of the vascular stent market has seen robust growth over the recent years. It is expected to rise from a $15.85 billion valuation in 2024 to $17.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.5%. This substantial growth during the historic period is driven by clinical studies and advancements, developments in drug-eluting stents (des), the emergence of balloon angioplasty, initial stent inventions, and improvements in physician training and skills.

How Much Will the Vascular Stent Market Be Worth in 2029?

The market size of vascular stents is anticipated to experience a swift expansion in the upcoming years, escalating to $25.76 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period can be linked to the emphasis on preventative care in cardiovascular health, the shift to outpatient procedures, price efficiency and value-driven healthcare, the emergence of bioabsorbable stents and next-gen materials, and the broadening scope of endovascular interventions. Key trends during this forecast period include improvements in the coatings and materials used for stents, increased patient knowledge and awareness, the movement towards outpatient settings, and an emphasis on cost-effectiveness.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Which is the Largest Company in the Vascular Stent Market?

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

What Are the Main Market Drivers in the Vascular Stent Industry?

The escalating occurrence of vascular disorders is expected to boost the vascular stent market’s progress. Vascular disease, a subset of cardiovascular diseases (CVD), is an abnormality affecting the blood vessels including arteries and veins. Vascular stents play a vital role in managing a variety of vascular diseases by facilitating the flow of oxygen-laden blood to the heart. For example, the Center for Disease Control and Prevention, an American public health federal agency, reported in May 2023 that in 2022, about 702,880 individuals in the United States succumbed to heart disease, equating to one in every five deaths. Consequently, rising instances of cardiovascular diseases (CVDs) will stimulate growth in the vascular stent market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8363&type=smp

How Is the Vascular Stent Market Segments Structured?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

What Strategic Trends Are Transforming the Vascular Stent Market?

The vascular stent market is increasingly influenced by the trend of technological advancements. Numerous firms are leveraging bio-sensing devices, top-notch integrated stents, and drug-deluting coronary stent systems for gaining a competitive advantage. For example, in 2022, India’s medical equipment manufacturing company, Translumina, introduced VIVO ISAR, an advanced generation polymer-free coated dual drug stent (DDCS) that pairs a stent with an enhanced safety profile without affecting the drug release kinetics. The stent uses Probucol, a lipid-lowering and antioxidant medication, to deliver Sirolimus, a drug combating restenosis, offering a polymer-free DES platform prioritizing safety and efficacy without any compromises.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Which Global Regions Offer the Highest Growth in the Vascular Stent Market?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

This Report Delivers Insight On:

1. How big is the vascular stent market, and how is it changing globally?

2. Who are the major companies in the vascular stent market, and how are they performing?

3. What are the key opportunities and risks in the vascular stent market right now?

4. Which products or customer segments are growing the most in the vascular stent market?

5. What factors are helping or slowing down the growth of the vascular stent market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Vascular Stent Market Size Changed, over the years?

The dimension of the vascular stent market has seen robust growth over the recent years. It is expected to rise from a $15.85 billion valuation in 2024 to $17.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.5%. This substantial growth during the historic period is driven by clinical studies and advancements, developments in drug-eluting stents (des), the emergence of balloon angioplasty, initial stent inventions, and improvements in physician training and skills.

How Much Will the Vascular Stent Market Be Worth in 2029?

The market size of vascular stents is anticipated to experience a swift expansion in the upcoming years, escalating to $25.76 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period can be linked to the emphasis on preventative care in cardiovascular health, the shift to outpatient procedures, price efficiency and value-driven healthcare, the emergence of bioabsorbable stents and next-gen materials, and the broadening scope of endovascular interventions. Key trends during this forecast period include improvements in the coatings and materials used for stents, increased patient knowledge and awareness, the movement towards outpatient settings, and an emphasis on cost-effectiveness.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Which is the Largest Company in the Vascular Stent Market?

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

What Are the Main Market Drivers in the Vascular Stent Industry?

The escalating occurrence of vascular disorders is expected to boost the vascular stent market’s progress. Vascular disease, a subset of cardiovascular diseases (CVD), is an abnormality affecting the blood vessels including arteries and veins. Vascular stents play a vital role in managing a variety of vascular diseases by facilitating the flow of oxygen-laden blood to the heart. For example, the Center for Disease Control and Prevention, an American public health federal agency, reported in May 2023 that in 2022, about 702,880 individuals in the United States succumbed to heart disease, equating to one in every five deaths. Consequently, rising instances of cardiovascular diseases (CVDs) will stimulate growth in the vascular stent market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8363&type=smp

How Is the Vascular Stent Market Segments Structured?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

What Strategic Trends Are Transforming the Vascular Stent Market?

The vascular stent market is increasingly influenced by the trend of technological advancements. Numerous firms are leveraging bio-sensing devices, top-notch integrated stents, and drug-deluting coronary stent systems for gaining a competitive advantage. For example, in 2022, India’s medical equipment manufacturing company, Translumina, introduced VIVO ISAR, an advanced generation polymer-free coated dual drug stent (DDCS) that pairs a stent with an enhanced safety profile without affecting the drug release kinetics. The stent uses Probucol, a lipid-lowering and antioxidant medication, to deliver Sirolimus, a drug combating restenosis, offering a polymer-free DES platform prioritizing safety and efficacy without any compromises.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Which Global Regions Offer the Highest Growth in the Vascular Stent Market?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

This Report Delivers Insight On:

1. How big is the vascular stent market, and how is it changing globally?

2. Who are the major companies in the vascular stent market, and how are they performing?

3. What are the key opportunities and risks in the vascular stent market right now?

4. Which products or customer segments are growing the most in the vascular stent market?

5. What factors are helping or slowing down the growth of the vascular stent market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Vascular Stent Market Size Changed, over the years?

The dimension of the vascular stent market has seen robust growth over the recent years. It is expected to rise from a $15.85 billion valuation in 2024 to $17.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.5%. This substantial growth during the historic period is driven by clinical studies and advancements, developments in drug-eluting stents (des), the emergence of balloon angioplasty, initial stent inventions, and improvements in physician training and skills.

How Much Will the Vascular Stent Market Be Worth in 2029?

The market size of vascular stents is anticipated to experience a swift expansion in the upcoming years, escalating to $25.76 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period can be linked to the emphasis on preventative care in cardiovascular health, the shift to outpatient procedures, price efficiency and value-driven healthcare, the emergence of bioabsorbable stents and next-gen materials, and the broadening scope of endovascular interventions. Key trends during this forecast period include improvements in the coatings and materials used for stents, increased patient knowledge and awareness, the movement towards outpatient settings, and an emphasis on cost-effectiveness.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Which is the Largest Company in the Vascular Stent Market?

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

What Are the Main Market Drivers in the Vascular Stent Industry?

The escalating occurrence of vascular disorders is expected to boost the vascular stent market’s progress. Vascular disease, a subset of cardiovascular diseases (CVD), is an abnormality affecting the blood vessels including arteries and veins. Vascular stents play a vital role in managing a variety of vascular diseases by facilitating the flow of oxygen-laden blood to the heart. For example, the Center for Disease Control and Prevention, an American public health federal agency, reported in May 2023 that in 2022, about 702,880 individuals in the United States succumbed to heart disease, equating to one in every five deaths. Consequently, rising instances of cardiovascular diseases (CVDs) will stimulate growth in the vascular stent market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8363&type=smp

How Is the Vascular Stent Market Segments Structured?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

What Strategic Trends Are Transforming the Vascular Stent Market?

The vascular stent market is increasingly influenced by the trend of technological advancements. Numerous firms are leveraging bio-sensing devices, top-notch integrated stents, and drug-deluting coronary stent systems for gaining a competitive advantage. For example, in 2022, India’s medical equipment manufacturing company, Translumina, introduced VIVO ISAR, an advanced generation polymer-free coated dual drug stent (DDCS) that pairs a stent with an enhanced safety profile without affecting the drug release kinetics. The stent uses Probucol, a lipid-lowering and antioxidant medication, to deliver Sirolimus, a drug combating restenosis, offering a polymer-free DES platform prioritizing safety and efficacy without any compromises.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Which Global Regions Offer the Highest Growth in the Vascular Stent Market?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

This Report Delivers Insight On:

1. How big is the vascular stent market, and how is it changing globally?

2. Who are the major companies in the vascular stent market, and how are they performing?

3. What are the key opportunities and risks in the vascular stent market right now?

4. Which products or customer segments are growing the most in the vascular stent market?

5. What factors are helping or slowing down the growth of the vascular stent market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the vascular stent industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Vascular Stent Market In 2029?

The size of the vascular stent market has seen significant expansion in the past few years. The market, which would be valued at $15.85 billion in 2024, is projected to reach a value of $17.36 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.5%. This marked growth during the historic period can be traced back to various factors such as clinical research and development, the usage of drug-eluting stents (des), the inception of balloon angioplasty, pioneering innovations in stent technology, and enhancements in physician training and skill development.

In the forthcoming years, the vascular stent market is projected to experience significant expansion. The market is forecasted to escalate to $25.76 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%. The market’s expansion during this period is attributable to several factors, including an emphasis on preventative cardiovascular care, a transition towards outpatient procedures, cost-effectiveness, value-based healthcare, bioabsorbable stents, and next-gen materials. The expansion of endovascular surgeries also fuels this growth. Key trends to note during this forecast period encompass enhancements in stent coating and materials, increasing patient enlightenment and cognizance, a shift towards outpatient facilities, and a focus on cost-efficiency.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Which Factors and External Forces Are Driving Demand in the Vascular Stent Market?

The growth of the vascular stent market is expected to be driven by an increase in the prevalence of vascular diseases. Vascular disease, a type of cardiovascular disorder, impairs the function of blood vessels, namely arteries and veins. Vascular stents play a critical role in treating these diseases by facilitating the circulation of oxygen-rich blood to the heart. For instance, the Center for Disease Control and Prevention, a prominent US-based public health agency, reported in May 2023 that in 2022 about 702,880 individuals succumbed to heart disease in the United States, representing 1 in every 5 deaths. Consequently, the escalating rate of cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the vascular stent market.

Which Segments in the Vascular Stent Offer the Most Growth?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8363&type=smp

What Are the Fastest-Growing Geographies in the Vascular Stent Market?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theVascular Stent Market’s Growth?

The rise of technology plays a significant role in the progress of the vascular stent market, a fact that is currently trending. To gain leverage in the market, various firms are directing investments towards the development of bio-sensing apparatus, advanced integrated stents, and systems that elude drugs within coronary stents. For example, Translumina, a company based out of India that manufactures medical equipment, debuted VIVO ISAR, a dual drug polymer-free coated stent (DDCS) of the latest generation, to the market in 2022. This innovative product combines a stent with an optimal safety profile yet does not compromise on the kinetics of drug release. It employs Probucol, a drug known to lower lipids and function as an antioxidant, to release Sirolimus (a medication to prevent restenosis), thus forming a polymer-free DES platform maintaining both safety and effectiveness.

View the full report here:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

What Are the Key Elements That Define the Vascular Stent Market?

A vascular stent refers to the small metal mesh tubular scaffolds that are used to prevent acute vessel closure and improve blood flow when a vein or artery is too narrow or blocked, resulting in late restenosis in a variety of vessels, such as coronary arteries. The procedure in which these stents are used is known as ‘vascular stenting.’ These stents are placed to widen arteries clogged with deposits and to facilitate fast recovery by reducing the risk of infection and physical trauma.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theVascular Stent Market?

The vascular stent market is expected to experience significant growth due to the rising prevalence of vascular diseases. Vascular disease, which refers to any condition that impacts veins and arteries, is a subcategory of cardiovascular diseases (CVD). Vascular stents play a critical role in the treatment of these conditions by facilitating the flow of oxygenated blood to the heart. For example, data from the US-based federal public health agency, the Center for Disease Control and Prevention, reveals that about 702,880 individuals succumbed to heart disease in the United States in 2022, accounting for one fifth of all deaths in that period. Thus, the escalating incidences of cardiovascular diseases are set to stimulate the expansion of the vascular stent market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

#What is the Projected CAGR for the Vascular Stent Market Size from 2025 to 2034?

In recent times, the market size of vascular stents has seen robust growth. The market is projected to increase from $15.85 billion in 2024 to approximately $17.36 billion in 2025, manifesting a Compound Annual Growth Rate (CAGR) of 9.5%. The augmentation in the historical period can be ascribed to facets such as clinical studies and advancements, introduction of drug-eluting stents (DES), initiation of balloon angioplasty, early stent inventions, and enhancement of physician skills and training.

Anticipated to see a significant escalation in the coming years, the size of the vascular stent market is projected to reach $25.76 billion by 2029, proliferating at a compound annual growth rate (CAGR) of 10.4%. The expansion during the expected period is linked to the emphasis on preventive care for cardiovascular conditions, transition to outpatient procedures, bioabsorbable stents and next-generation materials, value-oriented healthcare, and cost-effectiveness, as well as the growth of endovascular interventions. Moreover, the predicted developments throughout this period consist of innovations in stent coatings and materials, patient awareness and education, a shift towards outpatient venues, and a focus on cost efficiency.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

Which Cutting-Edge Market Trends Are Expected to Drive theVascular Stent Market’s Growth?

The increasing development in technology is a major trend emerging in the vascular stent market. Numerous businesses are allocating resources to bio-sensing gadgets, state-of-the-art integrated stents, and drug-eluting coronary stent systems to establish a competitive advantage in the industry. For example, in 2022, Translumina, a high-quality medical apparatus producer from India, introduced VIVO ISAR, a new generation dual drug polymer-free coated stent (DDCS) that combines a superior safety standard stent without losing drug release kinetics balance. This uses Probucol, a lipid-lowering and antioxidant medication, to serve as a carrier for Sirolimus (an anti-restenosis medication), thereby establishing a polymer-free DES platform that doesn’t compromise on safety or effectiveness.

What Are the Leading Market Players Impacting theVascular Stent Market’s Growth Trend?

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

How Are the Key Segments of the Vascular Stent Market Driving Opportunities and Innovations?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8363&type=smpGlobal Vascular Stent Market, Global Vascular Stent Market Report, Global Vascular Stent Market Trends, Global Vascular Stent Market Size

Browse Through More Reports Similar to the Gobal Vascular Stent Maret 2025, By The Business Research Company:

Peripheral Vascular Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Vascular Grafts Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report

Bioabsorbable Stents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the vascular stent market size evolved in recent years?

In recent years, the size of the vascular stent market has seen robust growth. The market is projected to expand from $15.85 billion in 2024 to $17.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. The increase during the historic period can be ascribed to factors including clinical research and innovation, the development of drug-eluting stents (DES), the advent of balloon angioplasty, initial stent breakthroughs, and advancements in physician training and skill development.

What are the predictions for the vascular stent market size in the coming years?

Expectations are high for the vascular stent market size to surge significantly in the coming years. Projected to escalate to $25.76 billion by 2029, this represents a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the anticipated growth in this period include an increased emphasis on preventive cardiovascular care, a move towards outpatient procedures, cost-effectiveness, the incorporation of value-based healthcare, the advent of bioabsorbable stents and next-generation materials, and the expansion of endovascular interventions. Several key trends within the forecast period contribute to this growth projection including advancements in stent coatings and materials, patient education and awareness, the movement towards outpatient settings, and an emphasis on cost effectiveness.

Get your vascular stent market report here!

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

What key factors are fueling the growth of the vascular stent market?

The escalation in cases of vascular diseases is anticipated to fuel the expansion of the vascular stent market. These diseases, which affect the blood vessels (both arteries and veins), are categorized under the broader umbrella of cardiovascular diseases (CVD). Vascular stents are a crucial part of the treatment for such ailments as they facilitate the transfer of oxygen-rich blood to the heart. For example, the US-based Center for Disease Control and Prevention revealed in May 2023 that heart disease claimed around 702,880 lives in the United States in 2022, equating to 1 in every 5 deaths. Hence, the prevalence of cardiovascular diseases (CVDs) is expected to spur the vascular stent market’s growth.

How is the global vascular stent market divided into key segments?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Who are the key firms paving the way for growth in the vascular stent market?

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

Which trends are expected to transform the vascular stent market?

In the vascular stent market, technological innovation is a rising trend. Numerous firms are focusing on investments in biosensing technology, cutting-edge integrated stents, and drug-eluting coronary stent systems to maintain a competitive position in the market. As an illustration, in 2022, an Indian medical equipment firm named Translumina launched an advanced generation dual drug polymer-free coated stent (DDCS), VIVO ISAR. This novel stent offers a superior safety profile without affecting drug release kinetics. It employs Probucol, a drug noted for its antioxidant and lipid-lowering properties, to carry Sirolimus, an anti-restenosis drug, therefore offering a safe and highly effective polymer-free DES platform.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8363

What regions are contributing significantly to the growth of the vascular stent market?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Peripheral Vascular Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Vascular Grafts Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report

Bioabsorbable Stents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the CAGR of the Vascular Stent Market Influence Its Overall Growth by 2034?

Significant growth has been seen in the vascular stent industry in the past few years. The industry, which is predicted to rise from $15.85 billion in 2024 to $17.36 billion in 2025, is forecasted to see a compound annual growth rate (CAGR) of 9.5%. The past growth can be linked to factors such as clinical studies and development, drug-eluting stents (des), the inception of balloon angioplasty, initial stent innovations, and the enhancement of physician training and skills.

The market size for vascular stents is projected to undergo substantial expansion in the upcoming years, rising to $25.76 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%. The anticipated growth over the forecast period can be credited to an emphasis on preemptive cardiovascular healthcare, migration to outpatient procedures, value-oriented and cost-effective healthcare, the use of bioabsorbable stents and innovative materials, and the broadening of endovascular interventions. Upcoming trends for the forecast period encompass progress in stent coatings and materials, patient knowledge and awareness, the shift towards outpatient environments, and concentration on economical efficiency.

Which Major Market Drivers Are Expected to Boost the vascular stent Market’s Growth Potential?

The escalating prevalence of vascular ailments is projected to bolster the expansion of the vascular stent market in the future. Vascular illnesses pertain to abnormal states that impact the blood vessels, such as arteries and veins, and comprise the group of cardiovascular diseases (CVD). Vascular stents play a crucial role in the management of numerous vascular maladies by facilitating the transport of oxygen-abundant blood to the heart. For example, data from the Center for Disease Control and Prevention, a US federal public health organization, revealed that heart disease claimed the lives of approximately 702,880 individuals in the United States in 2022, accounting for 1 in 5 fatalities. Consequently, a surge in cardiovascular diseases (CVDs) will spur the progress of the vascular stent market.

Request Your Free Vascular Stent Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

Who Are the Leading Companies Pioneering Change in the Vascular Stent Market?

Major companies operating in the vascular stent market are:

• Medtronic PLC_x000D_

• Abbott Laboratories_x000D_

• Boston Scientific Corporation_x000D_

• Biotronik SE & Co. KG_x000D_

• B. Braun Melsungen AG_x000D_

What Are the Most Significant Trends Transforming the Vascular Stent Market Today?

The vascular stent market is experiencing a significant trend with technology advancements. A plethora of companies are channeling investments into bio-sensing tools, innovative integrated stents, and drug-delivering coronary stent systems to gain market dominance. For instance, Translumina, a renowned medical equipment manufacturer from India, introduced VIVO ISAR in 2022. This is the latest generation dual drug polymer-free coated stent (DDCS) that marries a stent with a high safety standard without impacting the drug release kinetics. The stent utilizes Probucol, a lipid-lowering and antioxidant drug, as a delivery vehicle for Sirolimus, an anti-restenosis drug. This innovation paves the way for a polymer-free DES platform that doesn’t compromise on safety and effectiveness.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

What Are the Strategic Segments Comprising the Vascular Stent Market and Their Growth Contributions?

The vascular stent market covered in this report is segmented –

1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents

4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent

5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital

Subsegments:

1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents

2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents

3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts

Which Regions Are Leading the Charge in Vascular Stent Market Development?

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Vascular Stent Market Defined?

A vascular stent refers to the small metal mesh tubular scaffolds that are used to prevent acute vessel closure and improve blood flow when a vein or artery is too narrow or blocked, resulting in late restenosis in a variety of vessels, such as coronary arteries. The procedure in which these stents are used is known as ‘vascular stenting.’ These stents are placed to widen arteries clogged with deposits and to facilitate fast recovery by reducing the risk of infection and physical trauma.

Browse Through More Similar Reports By The Business Research Company:

Peripheral Vascular Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Vascular Grafts Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report

Bioabsorbable Stents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: